Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
PURPOSE: Bladder cancer recurrence occurs in 40% of patients following radical cystectomy (RC) and pelvic lymphadenectomy (PLND). Although recurrence can be reduced with adjuvant chemotherapy, the toxicity and low response rates of this treatment restrict its use to patients at highest risk. We dev...
Автори: | Catto, J, Abbod, M, Linkens, D, Larré, S, Rosario, D, Hamdy, F |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2009
|
Схожі ресурси
Схожі ресурси
-
Treatment Patterns and Radical Cystectomy Outcomes in Patients Diagnosed With Urothelial Nonmetastatic Muscle‐Invasive Bladder Cancer in the United States
за авторством: Bernard Bright Davies‐Teye, та інші
Опубліковано: (2025-02-01) -
Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology
за авторством: Vahid Mehrnoush, та інші
Опубліковано: (2022-09-01) -
Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder
за авторством: Wempy Supit, та інші
Опубліковано: (2014-10-01) -
Comparative study of intelligent models for the prediction of bladder cancer progression.
за авторством: Abbod, M, та інші
Опубліковано: (2006) -
The Prognostic Impact of Angiolymphatic Invasion in Bladder Urothelial Carcinoma Patients Undergoing Radical Cystectomy
за авторством: Jin Hyuck Kim, та інші
Опубліковано: (2023-03-01)